Köklü, Seyfettin <br/><br/>
 Daclatasvir plus asunaprevir dual therapy for chronic HCV genotype 1b infection: results of Turkish early access program.  [electronic resource] 

 -  Annals of hepatology   
 - 71-76 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1665-2681 
<br/><br/><label>Standard No.: </label>10.5604/16652681.1226817  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antiviral Agents--adverse effects<br/>Carbamates<br/>Cost-Benefit Analysis<br/>Drug Costs<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Health Services Accessibility--economics<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--diagnosis<br/>Humans<br/>Imidazoles--adverse effects<br/>Isoquinolines--adverse effects<br/>Male<br/>Middle Aged<br/>Program Evaluation<br/>Pyrrolidines<br/>RNA, Viral--genetics<br/>Sulfonamides--adverse effects<br/>Time Factors<br/>Treatment Outcome<br/>Turkey<br/>Valine--analogs & derivatives<br/>Viral Load